EUVIMEDEUVIMED entdecken
Crossref

Unlocking the Reverse Targeting Mechanisms of Cannabidiol: Unveiling New Therapeutic Avenues

Wen Zeng, Yifei Wang, Rui Gao, Hongliang Wen, Mingjia Yu iD

Journal of Medicinal Chemistry · 2024

DOI: 10.1021/acs.jmedchem.4c01353 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Wen Zeng und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, Beijing Institute of Technology, Beijing 100081, China. Hauptthemen laut MEDLINE: Cannabidiol, Molecular Dynamics Simulation, Receptors, G-Protein-Coupled, Molecular Docking Simulation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Beijing Institute of Technology Research Fund Program for Young Scholars, Beijing Institute of Technology Science and Technology Innovation Plan - Scientific Research Base Technology Support.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC), the main components of Cannabis sativa plants, have attracted a significant amount of attention due to their biological activities. This study identified GPR18 as the target of partial agonist CBD activating the p42/p44 MAPK pathway leading to migration of endometrial epithelial cells. Induced fit docking (IFD) showed that the affinity of THC for GPR18 is higher than that of CBD, and molecular dynamics (MD) simulations showed that CBD-GPR18 complexes at 130/200 ns might have stable conformations, potentially activating GPR18 by changing the distances of key residues in its active pocket. In contrast, THC maintains "metastable" conformations, generating a "shrinking space" leading to full agonism of THC by adding mechanical constraints in GPR18's active pocket. Steered molecular dynamics (SMD) revealed GPR18's active pocket was influenced more by CBD's partial agonism compared with THC. This combined IFD-MD-SMD method may be used to explain the mechanism of activation of partial or full agonists of GPR18.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabidiolMolecular Dynamics SimulationReceptors, G-Protein-CoupledMolecular Docking SimulationHumansDronabinolMitogen-Activated Protein Kinase 3Mitogen-Activated Protein Kinase 1Cell MovementFemale

Substanzen

CannabidiolReceptors, G-Protein-CoupledGPR18 protein, humanDronabinolMitogen-Activated Protein Kinase 3Mitogen-Activated Protein Kinase 1

Autor:innen und Institutionen

  • School of Chemistry and Chemical Engineering, Beijing Institute of Technology, Beijing 100081, China.
  • Key Laboratory of Medical Molecule Science and Pharmaceutical Engineering, Yangtze Delta Region Academy of Beijing Institute of Technology, Jiaxing 314019, China.

ORCID-Profile: Mingjia Yu

Förderung

  • National Natural Science Foundation of China
  • Beijing Institute of Technology Research Fund Program for Young Scholars
  • Beijing Institute of Technology Science and Technology Innovation Plan - Scientific Research Base Technology Support

Zitieren

APA

Zeng, W., Wang, Y., Gao, R., Wen, H., & Yu, M. (2024). Unlocking the Reverse Targeting Mechanisms of Cannabidiol: Unveiling New Therapeutic Avenues. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01353

Vancouver

Zeng W, Wang Y, Gao R, Wen H, Yu M. Unlocking the Reverse Targeting Mechanisms of Cannabidiol: Unveiling New Therapeutic Avenues. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c01353

BibTeX
@article{Zeng2024,
  author = {Zeng, Wen and Wang, Yifei and Gao, Rui and Wen, Hongliang and Yu, Mingjia},
  title = {Unlocking the Reverse Targeting Mechanisms of Cannabidiol: Unveiling New Therapeutic Avenues},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  doi = {10.1021/acs.jmedchem.4c01353}
}
Kostenlos starten →